Megan E. McNally
Megan E. McNally publishes mostly in Surgery, Hepatology and Pulmonary and Respiratory Medicine, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Neuroendocrine Tumor Research Advances and Cancer Genomics and Diagnostics.
- World rank
- #4,637,972 of 7,710,434 ranked researchers
- Rank in United States
- #1,225,454 of 1,627,098
- Works
- 28
- Citations
- 291
- Citations per work
- 10.4
What does Megan E. McNally research?
Megan E. McNally's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1655.7%
- Medicine1655.7%
- Everything else1137.7%
- Life Sciences26.6%
- 1Surgery18% of their works
- 2Hepatology12% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Oncology8% of their works
- 5Epidemiology8% of their works
- 6Cancer Research7% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Neuroendocrine Tumor Research Advances
- Cancer Genomics and Diagnostics
- Medical Coding and Health Information
- Lung Cancer Research Studies
- Genetic factors in colorectal cancer
- Lung Cancer Treatments and Mutations
- Cholangiocarcinoma and Gallbladder Cancer Studies
Which keywords describe Megan E. McNally's research?
The keywords of their largest research topics: Hepatocellular Carcinoma, Liver Cancer, Targeted Therapy, Clinical Trials, Prognostic Factors, Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors and ALK Inhibitors.
- Mutational Signatures
- Microsatellite Instability
- Genomic Profiles
- Clinical Coding
- Cancer Genomics
- ALK Inhibitors
- Neuroendocrine Tumors
- Clinical Trials
- Liver Cancer
- Hepatocellular Carcinoma
- Targeted Therapy
- Prognostic Factors
- Pancreatic Neuroendocrine Tumors
- Biliary Tract Cancer
- Cholangiocarcinoma
- EGFR Mutations
- ICD-10
- Molecular Characterization
- Small-Cell Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Hepatocellular Carcinoma61 topic
- Liver Cancer61 topic
- Targeted Therapy63 topics
- Clinical Trials42 topics
- Prognostic Factors42 topics
- Neuroendocrine Tumors31 topic
- Pancreatic Neuroendocrine Tumors31 topic
- ALK Inhibitors21 topic
- Biliary Tract Cancer21 topic
- Cancer Genomics21 topic
- Cholangiocarcinoma21 topic
- Clinical Coding21 topic
- EGFR Mutations21 topic
- Genomic Profiles21 topic
- ICD-1021 topic
- Microsatellite Instability21 topic
- Molecular Characterization21 topic
- Mutational Signatures21 topic
- Small-Cell Lung Cancer21 topic
Where does Megan E. McNally work?
Megan E. McNally's main affiliation in the publication record is University of Missouri–Kansas City, United States.
How many publications and citations does Megan E. McNally have?
OpenAlex counts 28 works and 291 citations for Megan E. McNally, an h-index of 8, ranking #4,637,972 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Megan E. McNally. Posts are plain text and can be reported.